The American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize the signs and symptoms of cyclic vomiting syndrome (CVS). CVS is a common and disabling condition, ...
Jul 16, 2024
0
0
In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical University of Munich (TUM) has discovered that cells in blood vessels ...
Jul 10, 2024
0
38
Refugees, internally displaced persons and migrants were exposed to significantly higher health risks during the COVID-19 pandemic than other population groups. A new study shows a 84% higher risk of infection and a 46% higher ...
Jul 11, 2024
0
1
COVID-19 is still killing around 1,700 people a week around the world, the World Health Organization said Thursday, as it urged at-risk populations to keep up with their vaccinations against the disease.
Jul 11, 2024
0
1
Cholestatic liver diseases (CLDs) are a group of disorders characterized by the impairment of bile formation, secretion, or excretion. This impairment leads to bile acid accumulation in the liver, causing liver biochemical ...
Jul 12, 2024
0
1
In a new study, Yale researchers identified a molecule that binds to a disease-associated macrophage migration inhibitory factor (MIF) gene variant. The discovery, they say, could lead to the development of a new generation ...
Jul 11, 2024
0
25
Subcutaneous delivery of an anti-TNF inhibitor drug improved remission rates in patients with moderate-to-severe Crohn's disease and ulcerative colitis, according to recent phase 3 clinical trial results published in the ...
21 hours ago
0
8
Over-the-counter nasal sprays could be a potent weapon against a major public health threat—antibiotic resistance, researchers report.
Jul 15, 2024
0
2
A new research paper titled "Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome" has been published in Aging.
Jul 10, 2024
0
0
An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue of The Journal of Urology.
Jul 11, 2024
0
0
